Ki Ho Lee

Title: Ki Ho Lee: Innovator in Pain Management

Introduction

Ki Ho Lee is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating pain, anxiety, and depression. With a total of 3 patents to his name, Lee continues to push the boundaries of medical innovation.

Latest Patents

One of Ki Ho Lee's latest patents is a method for treating pain, anxiety, or depression using a carbamoyloxy alkanoyl piperazine compound. This novel compound is characterized by its abundant racemic or enantiomeric properties, represented by a specific formula. The patent also includes a pharmaceutical composition that effectively utilizes this compound to treat various conditions in mammals. Another significant patent focuses on carbamoyloxy arylalkan arylpiperazine analgesics, which similarly aims to provide relief for pain, anxiety, and depression through the administration of the compound.

Career Highlights

Ki Ho Lee is currently associated with Sk Biopharmaceuticals Co., Ltd., where he applies his expertise in pharmaceutical development. His work has been instrumental in advancing treatments that address critical health issues, showcasing his commitment to improving patient outcomes.

Collaborations

Throughout his career, Ki Ho Lee has collaborated with notable colleagues, including Dae Joong Im and Eun Hee Chae. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical sector.

Conclusion

Ki Ho Lee stands out as a dedicated inventor whose work in pain management and mental health treatment is making a significant impact. His innovative approaches and collaborations continue to pave the way for advancements in the pharmaceutical industry.